NIH-funded research R21 grant

Understanding how coronavirus infects lung cells

Official title: Modeling the contribution of coronavirus cellular tropism to viral pathogenesis

Funded at Univ of North Carolina Chapel Hill · NIH-10747447 · Data updated 2026-11-12

This study is looking at how coronaviruses, like the one that causes COVID-19, infect lung cells by focusing on a special receptor called ACE2, using mice that have been modified to help us learn more about how the virus works and how we can better treat and prevent lung infections.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startDecember 1, 2022
Project endNovember 30, 2025
Funding year2024
Award (this year)$194,375
NIH project number5R21AI174225-02
Project IDNIH-10747447 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals with respiratory conditions or those at high risk for severe outcomes from coronavirus infections.

Less likely to help

Patients with non-respiratory conditions or those not affected by coronaviruses may not benefit from this research.

What this research studies

This research investigates how coronaviruses, like SARS-CoV-2, infect specific lung cells by focusing on the role of a receptor called ACE2. The researchers will create mouse models that express human ACE2 in certain airway cells to better understand how the virus enters these cells and causes disease. By examining these models, they aim to uncover the sequence of events that occur after exposure to the virus, which could lead to improved treatments and prevention strategies for lung infections.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for lung diseases caused by coronaviruses.

How similar studies have gone: Other research has shown success in using similar mouse models to study viral infections, indicating a promising approach for understanding coronavirus pathogenesis.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Koller, Beverly H — Univ of North Carolina Chapel Hill
  • Study coordinator: Koller, Beverly H

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.